|
LOC285033 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.856300E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.722000E-02 |
| Normal-vs-Stage2 |
4.438300E-02 |
| Normal-vs-Stage3 |
5.186900E-04 |
| Normal-vs-Stage4 |
1.259750E-03 |
| Stage1-vs-Stage2 |
3.481800E-01 |
| Stage1-vs-Stage3 |
1.688050E-02 |
| Stage1-vs-Stage4 |
2.447800E-02 |
| Stage2-vs-Stage3 |
4.365400E-01 |
| Stage2-vs-Stage4 |
3.972800E-01 |
| Stage3-vs-Stage4 |
8.687800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.563100E-03 |
| Normal-vs-AfricanAmerican |
1.081450E-01 |
| Normal-vs-Asian |
4.246200E-01 |
| Caucasian-vs-AfricanAmerican |
6.834200E-01 |
| Caucasian-vs-Asian |
1.154230E-01 |
| AfricanAmerican-vs-Asian |
2.058200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.764000E-04 |
| Normal-vs-Female |
9.791800E-02 |
| Male-vs-Female |
4.862000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.530500E-02 |
| Normal-vs-Age(41-60Yrs) |
4.393600E-02 |
| Normal-vs-Age(61-80Yrs) |
1.500840E-03 |
| Normal-vs-Age(81-100Yrs) |
6.263600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.036800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.057800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.301200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.649820E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.861000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.989000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.732200E-01 |
| Normal-vs-Grade 2 |
2.888300E-02 |
| Normal-vs-Grade 3 |
2.241300E-03 |
| Normal-vs-Grade 4 |
6.375300E-04 |
| Grade 1-vs-Grade 2 |
7.014400E-02 |
| Grade 1-vs-Grade 3 |
3.492000E-02 |
| Grade 1-vs-Grade 4 |
6.561800E-03 |
| Grade 2-vs-Grade 3 |
2.453600E-01 |
| Grade 2-vs-Grade 4 |
6.133700E-02 |
| Grade 3-vs-Grade 4 |
3.452800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.221500E-02 |
| Normal-vs-ccB subtype |
3.703500E-02 |
| ccA subtype-vs-ccB subtype |
9.296400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.940400E-02 |
| Normal-vs-N1 |
5.714300E-02 |
| N0-vs-N1 |
5.476400E-01 |
|
|
